10x Genomics Inc.

8.67
-0.06 (-0.69%)
At close: Apr 01, 2025, 3:59 PM
8.87
2.30%
After-hours: Apr 01, 2025, 06:00 PM EDT

10x Genomics Income Statement

Year FY24 FY23 FY22 FY21 FY20
Revenue 610.78M 618.73M 516.41M 490.49M 298.85M
Cost of Revenue 196.3M 209.41M 120.39M 74.09M 58.47M
Gross Profit 414.48M 409.31M 396.02M 416.4M 240.38M
Operating Income -194.56M -194.95M -167.94M -52.91M -85.32M
Interest Income 18.45M 16.91M 6.65M 206K 1.53M
Pretax Income -177.7M -248.76M -161.97M -53.72M -534.48M
Net Income -182.63M -255.1M -166M -58.22M -542.73M
Selling & General & Admin 344.34M 343.33M 298.3M 257.56M 202.33M
Research & Development 264.7M 270.33M 265.67M 211.75M 123.38M
Other Expenses n/a n/a -198K -802K 1.34M
Operating Expenses 609.04M 674.95M 563.97M 469.31M 325.7M
Interest Expense 4K 33K 476K 866K 1.68M
Selling & Marketing Expenses n/a 3.3M 3.7M 4.7M 1.9M
Cost & Expenses 805.34M 884.36M 684.35M 543.4M 384.17M
Income Tax 4.93M 6.34M 4.03M 4.51M 8.26M
Shares Outstanding (Basic) 120.45M 117.17M 113.86M 110.35M 101.15M
Shares Outstanding (Diluted) 120.45M 117.17M 113.86M 110.35M 101.15M
EPS (Basic) -1.52 -2.18 -1.46 -0.53 -5.37
EPS (Diluted) n/a n/a n/a n/a n/a
EBITDA -133.99M -205.11M -128.49M -24.59M -513.77M
Depreciation & Amortization 43.71M 43.62M 33.01M 28.25M 19.02M